Investor Relations

Webcast ImageWebcast
Pulse Biosciences Q4 2017 Earnings Call (Replay)
03/16/18 at 1:30 p.m. PT
Pulse Biosciences Q4 2017 Earnings Call
Friday, March 16, 2018 1:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate ProfilePulse Biosciences, Inc. is a medical technologies company developing commercial clinical applications for its proprietary Nano-Pulse Stimulation (“NPS”) technology. NPS is a novel patented technology leveraging nano-second duration energy pulses that have demonstrated effective local tumor control and the initiation of an adaptive immune response in pre-clinical studies. Pulse Biosciences is pursuing a number of clinical applications for NPS, including human oncology, dermatology, aesthetics and other minimally invasive applications where NPS is believed to provide greater benefits compared to current therapies and treatments.
Stock Quote PLSE (Common Stock) $14.52 - 0.61 (4.03%)
Today's Open$15.50
Previous Close$15.13
Data as of 03/19/18 4:00 p.m. ET

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: PLSE.O.  Currently trading at $14.52 with a 52 week high of $39.50 and a 52 week low of $9.81.
Recent News
Upcoming Events

There are currently no events scheduled.